Article Versions Notes

Safont G, Latorre I, Villar-Hernández R, Stojanovic Z, Marín A, Pérez-Cano C, Lacoma A, Molina-Moya B, Solis AJ, Arméstar F, et al. Measuring T-Cell Responses against SARS-CoV-2 Is of Utility for Disease and Vaccination Management. Journal of Clinical Medicine. 2022; 11(17):5103. https://doi.org/10.3390/jcm11175103

Safont, Guillem, Irene Latorre, Raquel Villar-Hernández, Zoran Stojanovic, Alicia Marín, Cristina Pérez-Cano, Alicia Lacoma, Bárbara Molina-Moya, Alan Jhunior Solis, Fernando Arméstar, and et al. 2022. "Measuring T-Cell Responses against SARS-CoV-2 Is of Utility for Disease and Vaccination Management" Journal of Clinical Medicine 11, no. 17: 5103. https://doi.org/10.3390/jcm11175103

Safont, G., Latorre, I., Villar-Hernández, R., Stojanovic, Z., Marín, A., Pérez-Cano, C., Lacoma, A., Molina-Moya, B., Solis, A. J., Arméstar, F., Matllo, J., Díaz-Fernández, S., Cendón, A., Sokalchuk, L., Tolosa, G., Casas, I., Rosell, A., & Domínguez, J. (2022). Measuring T-Cell Responses against SARS-CoV-2 Is of Utility for Disease and Vaccination Management. Journal of Clinical Medicine, 11(17), 5103. https://doi.org/10.3390/jcm11175103